Why the 340B Drug Discount Program Must Survive the Pandemic

Big Pharma has launched a stealth assault on a critically important drug discount program low income patients depend on for life-saving medicines and services – and make no mistake, lives are at stake.   The 340B program was created by Congress in the early 1990s to give safety-net providers access to reduced pricing they could not […]